View ValuationAmosenseLtd 将来の成長Future 基準チェック /06現在、 AmosenseLtdの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Electronic 収益成長40.4%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報Breakeven Date Change • Dec 31Forecast breakeven date pushed back to 2025The analyst covering AmosenseLtd previously expected the company to break even in 2024. New forecast suggests the company will make a profit of ₩10.5b in 2025. Average annual earnings growth of 74% is required to achieve expected profit on schedule.Breakeven Date Change • Dec 31Forecast breakeven date pushed back to 2024The analyst covering AmosenseLtd previously expected the company to break even in 2023. New forecast suggests the company will make a profit of ₩6.20b in 2024. Average annual earnings growth of 94% is required to achieve expected profit on schedule.Breakeven Date Change • Nov 30The analyst covering AmosenseLtd previously expected the company to break even in 2023. New forecast suggests the company will make a profit of ₩2.20b in 2023. Earnings growth of 1.9% is required to achieve expected profit on schedule.Breakeven Date Change • Nov 23Forecast to breakeven in 2023The analyst covering AmosenseLtd expects the company to break even for the first time. New forecast suggests the company will make a profit of ₩2.90b in 2023. Earnings growth of 77% is required to achieve expected profit on schedule.Breakeven Date Change • Nov 16Forecast breakeven date pushed back to 2023The analyst covering AmosenseLtd previously expected the company to break even in 2022. New forecast suggests losses will reduce by 100% to 2022. The company is expected to make a profit of ₩4.10b in 2023. Average annual earnings growth of 118% is required to achieve expected profit on schedule.Breakeven Date Change • Apr 27Forecast to breakeven in 2022The analyst covering AmosenseLtd expects the company to break even for the first time. New forecast suggests the company will make a profit of ₩6.90b in 2022. Earnings growth of 116% is required to achieve expected profit on schedule.すべての更新を表示Recent updatesNew Risk • Apr 09New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩146.6b (US$99.0m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.5x net interest cover). Share price has been highly volatile over the past 3 months (20% average weekly change). Revenue has declined by 9.0% over the past year. Minor Risks Less than 3 years of financial data is available. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.4% net profit margin). Market cap is less than US$100m (₩146.6b market cap, or US$99.0m).お知らせ • Feb 24Amosense Co.,Ltd., Annual General Meeting, Mar 24, 2026Amosense Co.,Ltd., Annual General Meeting, Mar 24, 2026, at 11:00 Tokyo Standard Time. Location: conference room, 90, 4sandan 5-gil, jiksan-eup, seobuk-gu, chungcheongnam-do, cheonan South KoreaNew Risk • Feb 11New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 10% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risk Share price has been volatile over the past 3 months (10% average weekly change).New Risk • Aug 29New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (11% average weekly change). Minor Risk Market cap is less than US$100m (₩98.6b market cap, or US$70.9m).New Risk • Aug 13New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Market cap is less than US$100m (₩78.3b market cap, or US$56.6m).分析記事 • Jun 02Not Many Are Piling Into Amosense Co.,Ltd. (KOSDAQ:357580) Just YetThere wouldn't be many who think Amosense Co.,Ltd.'s ( KOSDAQ:357580 ) price-to-sales (or "P/S") ratio of 0.6x is worth...Valuation Update With 7 Day Price Move • Jun 02Investor sentiment improves as stock rises 28%After last week's 28% share price gain to ₩7,380, the stock trades at a trailing P/E ratio of 47.6x. Average trailing P/E is 14x in the Electronic industry in South Korea. Total loss to shareholders of 58% over the past three years.New Risk • Feb 21New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -₩19b This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-₩19b free cash flow). Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Market cap is less than US$100m (₩70.4b market cap, or US$49.1m).お知らせ • Feb 21Amosense Co.,Ltd., Annual General Meeting, Mar 24, 2025Amosense Co.,Ltd., Annual General Meeting, Mar 24, 2025, at 11:30 Tokyo Standard Time. Location: conference room, 20-3, 4sandan 2-gil, jiksan-eup, seobuk-gu, chungcheongnam-do, cheonan South KoreaBuy Or Sell Opportunity • Feb 11Now 21% undervaluedOver the last 90 days, the stock has risen 1.4% to ₩6,340. The fair value is estimated to be ₩8,008, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 30% over the last 3 years. Earnings per share has grown by 57%.分析記事 • Feb 10Amosense Co.,Ltd.'s (KOSDAQ:357580) Shares Leap 27% Yet They're Still Not Telling The Full StoryAmosense Co.,Ltd. ( KOSDAQ:357580 ) shareholders would be excited to see that the share price has had a great month...分析記事 • Feb 07Is It Too Late To Consider Buying Amosense Co.,Ltd. (KOSDAQ:357580)?While Amosense Co.,Ltd. ( KOSDAQ:357580 ) might not have the largest market cap around , it led the KOSDAQ gainers with...New Risk • Feb 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Less than 1 year of cash runway based on current free cash flow (-₩19b). Share price has been volatile over the past 3 months (11% average weekly change). Market cap is less than US$100m (₩75.1b market cap, or US$51.9m).Breakeven Date Change • Dec 31Forecast breakeven date pushed back to 2025The analyst covering AmosenseLtd previously expected the company to break even in 2024. New forecast suggests the company will make a profit of ₩10.5b in 2025. Average annual earnings growth of 74% is required to achieve expected profit on schedule.New Risk • Dec 16New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risk Market cap is less than US$100m (₩62.8b market cap, or US$43.7m).分析記事 • Dec 09Returns On Capital At AmosenseLtd (KOSDAQ:357580) Paint A Concerning PictureTo find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'd want to...Buy Or Sell Opportunity • Nov 27Now 23% undervalued after recent price dropOver the last 90 days, the stock has fallen 22% to ₩6,130. The fair value is estimated to be ₩7,976, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 28% over the last 3 years. Earnings per share has grown by 78%.分析記事 • Nov 12Potential Upside For Amosense Co.,Ltd. (KOSDAQ:357580) Not Without RiskIt's not a stretch to say that Amosense Co.,Ltd.'s ( KOSDAQ:357580 ) price-to-sales (or "P/S") ratio of 0.6x seems...Buy Or Sell Opportunity • Nov 12Now 22% undervalued after recent price dropOver the last 90 days, the stock has fallen 22% to ₩6,320. The fair value is estimated to be ₩8,120, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 28% over the last 3 years. Earnings per share has grown by 78%.分析記事 • Aug 05Amosense Co.,Ltd. (KOSDAQ:357580) Stock's 26% Dive Might Signal An Opportunity But It Requires Some ScrutinyAmosense Co.,Ltd. ( KOSDAQ:357580 ) shareholders that were waiting for something to happen have been dealt a blow with...Valuation Update With 7 Day Price Move • Aug 05Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₩7,510, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 11x in the Electronic industry in South Korea. Total loss to shareholders of 56% over the past three years.New Risk • Jun 08New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 1.7x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.7x net interest cover). High level of non-cash earnings (44% accrual ratio). Minor Risk Market cap is less than US$100m (₩130.9b market cap, or US$94.9m).お知らせ • Apr 27Amosense Co.,Ltd. announced that it has received KRW 10 billion in funding from KB Investment Co., Ltd, Mirae Asset Securities Co., Ltd., Shinhan Investment & Securities Co., Ltd., EBEST Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., Samsung Securities Co.,Ltd.On April 26, 2024, Amosense Co.,Ltd. closed the transaction.お知らせ • Apr 24Amosense Co.,Ltd. announced that it expects to receive KRW 10 billion in funding from KB Investment Co., Ltd, Mirae Asset Securities Co., Ltd., Shinhan Investment & Securities Co., Ltd., EBEST Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., Samsung Securities Co.,Ltd.Amosense Co.,Ltd announced a private placement of Series 2 Bearer-bearing interest-bearing, unsecured private placement convertible bonds for gross proceeds of KRW 10,000,000,000 on April 24, 2024. The transaction includes participation from Mirae Asset Securities Co., Ltd, Shinhan Investment & Securities Co., Ltd., EBEST INVESTMENT & SECURITIES Co., Ltd, KB Securities Co., Ltd., NH Investment & Securities Co., Ltd. and Samsung Securities Co., Ltd. The Notes bear interest rate of zero percent and matures on April 26, 2029. The notes are convertible into 868,281 shares with a conversion price of KRW 11,517 per share representing conversion rate of 7.18%. Conversion claim period is April 26, 2025 to March 26, 2029. The transaction has been approved by the board of directors of the company. The transaction is expected to close on April 26, 2024.Breakeven Date Change • Dec 31Forecast breakeven date pushed back to 2024The analyst covering AmosenseLtd previously expected the company to break even in 2023. New forecast suggests the company will make a profit of ₩6.20b in 2024. Average annual earnings growth of 94% is required to achieve expected profit on schedule.Breakeven Date Change • Nov 30The analyst covering AmosenseLtd previously expected the company to break even in 2023. New forecast suggests the company will make a profit of ₩2.20b in 2023. Earnings growth of 1.9% is required to achieve expected profit on schedule.Breakeven Date Change • Nov 23Forecast to breakeven in 2023The analyst covering AmosenseLtd expects the company to break even for the first time. New forecast suggests the company will make a profit of ₩2.90b in 2023. Earnings growth of 77% is required to achieve expected profit on schedule.New Risk • Oct 10New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩132.4b (US$98.3m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (16% average weekly change). Minor Risk Market cap is less than US$100m (₩132.4b market cap, or US$98.3m).New Risk • Aug 19New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.Breakeven Date Change • Nov 16Forecast breakeven date pushed back to 2023The analyst covering AmosenseLtd previously expected the company to break even in 2022. New forecast suggests losses will reduce by 100% to 2022. The company is expected to make a profit of ₩4.10b in 2023. Average annual earnings growth of 118% is required to achieve expected profit on schedule.Breakeven Date Change • Apr 27Forecast to breakeven in 2022The analyst covering AmosenseLtd expects the company to break even for the first time. New forecast suggests the company will make a profit of ₩6.90b in 2022. Earnings growth of 116% is required to achieve expected profit on schedule. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、AmosenseLtd は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測KOSDAQ:A357580 - アナリストの将来予測と過去の財務データ ( )KRW Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/2025122,1404976,09811,384N/A9/30/2025127,7922,61710,72915,649N/A6/30/2025133,3414,7645,87111,787N/A3/31/2025135,3323,2415,09512,555N/A12/31/2024134,1551,739-10,926-494N/Aアナリストによる今後の成長予測収入対貯蓄率: A357580の予測収益成長が 貯蓄率 ( 3.1% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: A357580の収益がKR市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: A357580の収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: A357580の収益がKR市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: A357580の収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: A357580の 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YTech 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/17 08:43終値2026/05/15 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Amosense Co.,Ltd. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Kang Ho OhShinhan Investment Corp.
Breakeven Date Change • Dec 31Forecast breakeven date pushed back to 2025The analyst covering AmosenseLtd previously expected the company to break even in 2024. New forecast suggests the company will make a profit of ₩10.5b in 2025. Average annual earnings growth of 74% is required to achieve expected profit on schedule.
Breakeven Date Change • Dec 31Forecast breakeven date pushed back to 2024The analyst covering AmosenseLtd previously expected the company to break even in 2023. New forecast suggests the company will make a profit of ₩6.20b in 2024. Average annual earnings growth of 94% is required to achieve expected profit on schedule.
Breakeven Date Change • Nov 30The analyst covering AmosenseLtd previously expected the company to break even in 2023. New forecast suggests the company will make a profit of ₩2.20b in 2023. Earnings growth of 1.9% is required to achieve expected profit on schedule.
Breakeven Date Change • Nov 23Forecast to breakeven in 2023The analyst covering AmosenseLtd expects the company to break even for the first time. New forecast suggests the company will make a profit of ₩2.90b in 2023. Earnings growth of 77% is required to achieve expected profit on schedule.
Breakeven Date Change • Nov 16Forecast breakeven date pushed back to 2023The analyst covering AmosenseLtd previously expected the company to break even in 2022. New forecast suggests losses will reduce by 100% to 2022. The company is expected to make a profit of ₩4.10b in 2023. Average annual earnings growth of 118% is required to achieve expected profit on schedule.
Breakeven Date Change • Apr 27Forecast to breakeven in 2022The analyst covering AmosenseLtd expects the company to break even for the first time. New forecast suggests the company will make a profit of ₩6.90b in 2022. Earnings growth of 116% is required to achieve expected profit on schedule.
New Risk • Apr 09New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩146.6b (US$99.0m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.5x net interest cover). Share price has been highly volatile over the past 3 months (20% average weekly change). Revenue has declined by 9.0% over the past year. Minor Risks Less than 3 years of financial data is available. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.4% net profit margin). Market cap is less than US$100m (₩146.6b market cap, or US$99.0m).
お知らせ • Feb 24Amosense Co.,Ltd., Annual General Meeting, Mar 24, 2026Amosense Co.,Ltd., Annual General Meeting, Mar 24, 2026, at 11:00 Tokyo Standard Time. Location: conference room, 90, 4sandan 5-gil, jiksan-eup, seobuk-gu, chungcheongnam-do, cheonan South Korea
New Risk • Feb 11New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 10% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risk Share price has been volatile over the past 3 months (10% average weekly change).
New Risk • Aug 29New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (11% average weekly change). Minor Risk Market cap is less than US$100m (₩98.6b market cap, or US$70.9m).
New Risk • Aug 13New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Market cap is less than US$100m (₩78.3b market cap, or US$56.6m).
分析記事 • Jun 02Not Many Are Piling Into Amosense Co.,Ltd. (KOSDAQ:357580) Just YetThere wouldn't be many who think Amosense Co.,Ltd.'s ( KOSDAQ:357580 ) price-to-sales (or "P/S") ratio of 0.6x is worth...
Valuation Update With 7 Day Price Move • Jun 02Investor sentiment improves as stock rises 28%After last week's 28% share price gain to ₩7,380, the stock trades at a trailing P/E ratio of 47.6x. Average trailing P/E is 14x in the Electronic industry in South Korea. Total loss to shareholders of 58% over the past three years.
New Risk • Feb 21New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -₩19b This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-₩19b free cash flow). Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Market cap is less than US$100m (₩70.4b market cap, or US$49.1m).
お知らせ • Feb 21Amosense Co.,Ltd., Annual General Meeting, Mar 24, 2025Amosense Co.,Ltd., Annual General Meeting, Mar 24, 2025, at 11:30 Tokyo Standard Time. Location: conference room, 20-3, 4sandan 2-gil, jiksan-eup, seobuk-gu, chungcheongnam-do, cheonan South Korea
Buy Or Sell Opportunity • Feb 11Now 21% undervaluedOver the last 90 days, the stock has risen 1.4% to ₩6,340. The fair value is estimated to be ₩8,008, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 30% over the last 3 years. Earnings per share has grown by 57%.
分析記事 • Feb 10Amosense Co.,Ltd.'s (KOSDAQ:357580) Shares Leap 27% Yet They're Still Not Telling The Full StoryAmosense Co.,Ltd. ( KOSDAQ:357580 ) shareholders would be excited to see that the share price has had a great month...
分析記事 • Feb 07Is It Too Late To Consider Buying Amosense Co.,Ltd. (KOSDAQ:357580)?While Amosense Co.,Ltd. ( KOSDAQ:357580 ) might not have the largest market cap around , it led the KOSDAQ gainers with...
New Risk • Feb 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Less than 1 year of cash runway based on current free cash flow (-₩19b). Share price has been volatile over the past 3 months (11% average weekly change). Market cap is less than US$100m (₩75.1b market cap, or US$51.9m).
Breakeven Date Change • Dec 31Forecast breakeven date pushed back to 2025The analyst covering AmosenseLtd previously expected the company to break even in 2024. New forecast suggests the company will make a profit of ₩10.5b in 2025. Average annual earnings growth of 74% is required to achieve expected profit on schedule.
New Risk • Dec 16New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risk Market cap is less than US$100m (₩62.8b market cap, or US$43.7m).
分析記事 • Dec 09Returns On Capital At AmosenseLtd (KOSDAQ:357580) Paint A Concerning PictureTo find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'd want to...
Buy Or Sell Opportunity • Nov 27Now 23% undervalued after recent price dropOver the last 90 days, the stock has fallen 22% to ₩6,130. The fair value is estimated to be ₩7,976, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 28% over the last 3 years. Earnings per share has grown by 78%.
分析記事 • Nov 12Potential Upside For Amosense Co.,Ltd. (KOSDAQ:357580) Not Without RiskIt's not a stretch to say that Amosense Co.,Ltd.'s ( KOSDAQ:357580 ) price-to-sales (or "P/S") ratio of 0.6x seems...
Buy Or Sell Opportunity • Nov 12Now 22% undervalued after recent price dropOver the last 90 days, the stock has fallen 22% to ₩6,320. The fair value is estimated to be ₩8,120, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 28% over the last 3 years. Earnings per share has grown by 78%.
分析記事 • Aug 05Amosense Co.,Ltd. (KOSDAQ:357580) Stock's 26% Dive Might Signal An Opportunity But It Requires Some ScrutinyAmosense Co.,Ltd. ( KOSDAQ:357580 ) shareholders that were waiting for something to happen have been dealt a blow with...
Valuation Update With 7 Day Price Move • Aug 05Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₩7,510, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 11x in the Electronic industry in South Korea. Total loss to shareholders of 56% over the past three years.
New Risk • Jun 08New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 1.7x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.7x net interest cover). High level of non-cash earnings (44% accrual ratio). Minor Risk Market cap is less than US$100m (₩130.9b market cap, or US$94.9m).
お知らせ • Apr 27Amosense Co.,Ltd. announced that it has received KRW 10 billion in funding from KB Investment Co., Ltd, Mirae Asset Securities Co., Ltd., Shinhan Investment & Securities Co., Ltd., EBEST Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., Samsung Securities Co.,Ltd.On April 26, 2024, Amosense Co.,Ltd. closed the transaction.
お知らせ • Apr 24Amosense Co.,Ltd. announced that it expects to receive KRW 10 billion in funding from KB Investment Co., Ltd, Mirae Asset Securities Co., Ltd., Shinhan Investment & Securities Co., Ltd., EBEST Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., Samsung Securities Co.,Ltd.Amosense Co.,Ltd announced a private placement of Series 2 Bearer-bearing interest-bearing, unsecured private placement convertible bonds for gross proceeds of KRW 10,000,000,000 on April 24, 2024. The transaction includes participation from Mirae Asset Securities Co., Ltd, Shinhan Investment & Securities Co., Ltd., EBEST INVESTMENT & SECURITIES Co., Ltd, KB Securities Co., Ltd., NH Investment & Securities Co., Ltd. and Samsung Securities Co., Ltd. The Notes bear interest rate of zero percent and matures on April 26, 2029. The notes are convertible into 868,281 shares with a conversion price of KRW 11,517 per share representing conversion rate of 7.18%. Conversion claim period is April 26, 2025 to March 26, 2029. The transaction has been approved by the board of directors of the company. The transaction is expected to close on April 26, 2024.
Breakeven Date Change • Dec 31Forecast breakeven date pushed back to 2024The analyst covering AmosenseLtd previously expected the company to break even in 2023. New forecast suggests the company will make a profit of ₩6.20b in 2024. Average annual earnings growth of 94% is required to achieve expected profit on schedule.
Breakeven Date Change • Nov 30The analyst covering AmosenseLtd previously expected the company to break even in 2023. New forecast suggests the company will make a profit of ₩2.20b in 2023. Earnings growth of 1.9% is required to achieve expected profit on schedule.
Breakeven Date Change • Nov 23Forecast to breakeven in 2023The analyst covering AmosenseLtd expects the company to break even for the first time. New forecast suggests the company will make a profit of ₩2.90b in 2023. Earnings growth of 77% is required to achieve expected profit on schedule.
New Risk • Oct 10New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩132.4b (US$98.3m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (16% average weekly change). Minor Risk Market cap is less than US$100m (₩132.4b market cap, or US$98.3m).
New Risk • Aug 19New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
Breakeven Date Change • Nov 16Forecast breakeven date pushed back to 2023The analyst covering AmosenseLtd previously expected the company to break even in 2022. New forecast suggests losses will reduce by 100% to 2022. The company is expected to make a profit of ₩4.10b in 2023. Average annual earnings growth of 118% is required to achieve expected profit on schedule.
Breakeven Date Change • Apr 27Forecast to breakeven in 2022The analyst covering AmosenseLtd expects the company to break even for the first time. New forecast suggests the company will make a profit of ₩6.90b in 2022. Earnings growth of 116% is required to achieve expected profit on schedule.